Rapamycin causes activation of protein phosphatase-2A1 and nuclear translocation of PCNA in CD4+ T cells

Biochem Biophys Res Commun. 2004 Oct 15;323(2):645-51. doi: 10.1016/j.bbrc.2004.08.147.

Abstract

Rapamycin is a powerful immunosuppressant that causes cell cycle arrest in T cells and several other cell types. Despite its important clinical role, the mechanism of action of rapamycin is not fully understood. Here, we show that rapamycin causes the activation of protein phosphatase-2A1 which forms a complex with proliferation cell nuclear antigen (PCNA) in a CD4+ T cell line. Rapamycin also induces PCNA translocation from the cytoplasm to the nucleus, an effect which is antagonized by okadaic acid, an inhibitor of type 2A protein phosphatases. These findings provide evidence for the existence of a signal transduction pathway that links a rapamycin-activated type 2A protein phosphatase to the control of DNA synthesis, DNA repair, cell cycle, and cell death via PCNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects*
  • Enzyme Activation / drug effects
  • Enzyme Activation / immunology
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Jurkat Cells
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphoprotein Phosphatases / immunology*
  • Phosphoprotein Phosphatases / metabolism*
  • Proliferating Cell Nuclear Antigen / immunology*
  • Proliferating Cell Nuclear Antigen / metabolism*
  • Sirolimus / pharmacology*

Substances

  • Immunosuppressive Agents
  • Proliferating Cell Nuclear Antigen
  • Phosphoprotein Phosphatases
  • Sirolimus